MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-24-0005772
Brugen Pharmaceuticals Private Limited
Brugen Pharmaceuticals Private Limited - chemicals in Jabalpur, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.23 Lakh
▲ 88% YoY
Net loss · FY 2025
₹30,694
Net margin -2.7%
EBITDA · FY 2025
-₹2,019
EBITDA margin -0.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Brugen Pharmaceuticals Private Limited
Data last updated:
Brugen Pharmaceuticals Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 14 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24297MP2020PTC053281. Its GSTIN is 23AAJCB3520E1Z9 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjeev Roy and Prabha Roy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hno. C/4 Gulomohar Residency South Civil Lines, Jabalpur, Madhya Pradesh, India – 482001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.23 Lakh, a growth of 88% compared to the previous year. For the same year it recorded a net loss of ₹30,694 (net margin -2.7%) and EBITDA of -₹2,019 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
Brugen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0005772).
Company details
CIN U24297MP2020PTC053281
Registration Number 053281
Incorporation Date 14 October 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-24-0005772
Key People
Sanjeev Roy Director Prabha Roy Director Recognitions & Rankings of Brugen Pharmaceuticals
Contact details
Brugen Pharmaceuticals Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressHno. C/4 Gulomohar Residency South Civil Lines, Jabalpur, Madhya Pradesh, India – 482001
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
To see the full contact details of Brugen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Brugen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Brugen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Brugen Pharmaceuticals Private Limited, buy the company report.
Financials of Brugen Pharmaceuticals Private Limited
FY 2025 filings availableBrugen Pharmaceuticals Private Limited reported revenue of ₹11.23 Lakh (up 88% YoY) for FY 2025.
Revenue · FY 2025
₹11.23 Lakh ▲ 88%
Net loss · FY 2025
₹30,694 margin -2.7%
EBITDA · FY 2025
-₹2,019 margin -0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 88%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▼ 27%
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 88% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2,019 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30,694 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brugen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brugen Pharmaceuticals Private Limited
Brugen Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Roy | Director | 14 Oct 2020 | 6 Years 0 Months | Current |
| Prabha Roy | Director | 14 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Brugen Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zostera Pharmaceuticals Private Limited | ₹11.27 Lakh (FY 2016) | -22.0% | Ahmedabad, Gujarat, India | |||
| A C Pharmaceuticals Pvt Ltd | ₹11.26 Lakh (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Delbert Pharmaceuticals Private Limited | ₹11.25 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Brugen Pharmaceuticals Private Limitedthis company | ₹11.23 Lakh (FY 2025) | -₹30,694 | -2.7% | 88.0% | Jabalpur, Madhya Pradesh, India | |
| Panmed Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2017) | -49.0% | Chennai, Tamil Nadu, India | |||
| Rynn Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2024) | -39.0% | Ghaziabad, Uttar Pradesh, India | |||
| Fronde Pharmaceuticals Private Limited | ₹11.2 Lakh (FY 2025) | -8.0% | Cuttack, Odisha, India | |||
| Altmann Pharmaceuticals Private Limited | ₹11.17 Lakh (FY 2025) | 30.0% | Karnal, Haryana, India | |||
| Specura Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2025) | 48.0% | Pune, Maharashtra, India |
To see the full peer comparison of Brugen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brugen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brugen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Brugen Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Brugen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCB3520E1Z9 | Madhya Pradesh | Active | 05 Jan 2021 |
To see the full GST registrations and return filing status of Brugen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Brugen Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prabha Roy was appointed as Director on 14 Oct 2020.
AGM
Brugen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Brugen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Prabha Roy was appointed as Director.
Appointed
Sanjeev Roy was appointed as Director.
Incorporation
14 Oct 2020
Brugen Pharmaceuticals Private Limited was registered on 14 Oct 2020 with Roc Gwalior & aged 6 years 21 days as per MCA records.
Frequently asked questions
Brugen Pharmaceuticals is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 14 October 2020 (6+ years old) and is registered under CIN U24297MP2020PTC053281.
Brugen Pharmaceuticals has 2 current directors:
- Sanjeev Roy - Director
- Prabha Roy - Director
The latest financial statements of Brugen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Brugen Pharmaceuticals is 23AAJCB3520E1Z9, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Brugen Pharmaceuticals is U24297MP2020PTC053281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brugen Pharmaceuticals was incorporated on 14 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Brugen Pharmaceuticals by revenue are Zostera Pharmaceuticals Private Limited, A C Pharmaceuticals Pvt Ltd, Delbert Pharmaceuticals Private Limited, Panmed Pharmaceuticals Private Limited, Rynn Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prabha Roy was appointed as Director on 14 Oct 2020. Sanjeev Roy was appointed as Director on 14 Oct 2020.
Yes, Brugen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-24-0005772).
The registered office of Brugen Pharmaceuticals is at Hno. C4 Gulomohar Residency South Civil Lines, Jabalpur, Madhya Pradesh, India – 482001.
Brugen Pharmaceuticals operates in the chemicals industry, in the chemical products or preparations of a kind used in the textiles segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages